Top-News
Biotechnologie Großbritannien

Adaptimmune Therapeutics Plc. ADR News

Aktie
WKN:  A14SUX ISIN:  US00653A1079 US-Symbol:  ADAP
0,995 €
-0,045 €
-4,33%
20:44:01 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
227,12 Mio.
Marktkapitalisierung *
231,95 Mio. €
Streubesitz
-
Faktor
6
Originalaktie
GB00BVYV1687
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 03.01.2024

Adaptimmune Therapeutics Plc. ADR News

11.04.23 - PR Newswire
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ROCC, KBAL, ADAP, TCRR
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ROCC, KBAL, ADAP, TCRR PR Newswire
06.04.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RADI, ADAP, TCRR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RADI, ADAP, TCRR PR Newswire
28.03.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROCC, RADI, ADAP, TCRR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROCC, RADI, ADAP, TCRR PR Newswire
23.03.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSEY, ADAP, TCRR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSEY, ADAP, TCRR PR Newswire
07.03.23 - PR Newswire
INVESTIGATION ALERT: Halper Sadeh LLC Investigates RADI, ADAP, TCRR, ROCC
INVESTIGATION ALERT: Halper Sadeh LLC Investigates RADI, ADAP, TCRR, ROCC PR Newswire
14.03.22 - PR Newswire
Thinking about buying stock in Turquoise Hill Resources, Mullen Automotive, Frontier Group, Adaptimmune Therapeutics, or Nokia?
Thinking about buying stock in Turquoise Hill Resources, Mullen Automotive, Frontier Group, Adaptimmune Therapeutics, or Nokia? PR Newswire
15.09.21 - PR Newswire
Thinking about buying stock in Microvast, FuelCell Energy, Workhorse Group, Adaptimmune Therapeutics, or American Resources?
Thinking about buying stock in Microvast, FuelCell Energy, Workhorse Group, Adaptimmune Therapeutics, or American Resources? PR Newswire
13.09.21 - PR Newswire
Thinking about buying stock in Leap Therapeutics, Aterian, Hepion Pharmaceuticals, Adaptimmune Therapeutics, or Endo International?
Thinking about buying stock in Leap Therapeutics, Aterian, Hepion Pharmaceuticals, Adaptimmune Therapeutics, or Endo International? PR Newswire
09.09.21 - Der Aktionär
Roche‑Tochter Genentech lässt Adaptimmune‑Aktie fliegen – dieser AKTIONÄR‑Hot‑Stock profitiert vom Top‑Deal
07.09.21 - PR Newswire
Thinking about buying stock in Adaptimmune Therapeutics, Ziopharm Oncology, Uniqure NV, GlycoMimetics, or AbCellera Biologics?
Thinking about buying stock in Adaptimmune Therapeutics, Ziopharm Oncology, Uniqure NV, GlycoMimetics, or AbCellera Biologics? PR Newswire
20.05.21 - PR Newswire
Thinking about buying stock in Oncternal Therapeutics, Polarityte, Adaptimmune Therapeutics, Oncolytics Biotech, or Precipio?
Thinking about buying stock in Oncternal Therapeutics, Polarityte, Adaptimmune Therapeutics, Oncolytics Biotech, or Precipio? PR Newswire
02.06.20 - PR Newswire
Thinking about buying stock in Tenax Therapeutics, Allena Pharmaceuticals, Trevena, Adaptimmune Therapeutics, or Aurora Cannabis?
Thinking about buying stock in Tenax Therapeutics, Allena Pharmaceuticals, Trevena, Adaptimmune Therapeutics, or Aurora Cannabis? PR Newswire
12.05.20 - PR Newswire
Thinking about buying stock in Adaptimmune Therapeutics, Upwork, Eldorado Resorts, Co-Diagnostics, or Delta Air Lines?
Thinking about buying stock in Adaptimmune Therapeutics, Upwork, Eldorado Resorts, Co-​Diagnostics, or Delta Air Lines? PR Newswire
13.02.19 - Der Aktionär
Medigene-Rivale Adaptimmune: "Wir lernen ständig mehr darüber"
17.01.18 - Der Aktionär
Biotech-Szene im Übernahmefieber: Fantasie bei Bluebird Bio, Medigene und Co
08.01.18 - GlobeNewswire
Adaptimmune Announces Two Manufacturing Achievements on Its way to Become the First Fully Integrated TCR T-cell Therapy Company
Adaptimmune Announces Two Manufacturing Achievements on Its way to Become the First Fully Integrated TCR T-cell Therapy Company Successful Manufacturing of SPEAR T-...
06.11.17 - GlobeNewswire
Adaptimmune marks Official Opening of U.K. Headquarters
Adaptimmune marks Official Opening of U.K. Headquarters Flagship Facility is new Base for U.K. Research and Development Operations PHILADELPHIA and OXFORD, U.K., Nov. ...
07.09.17 - GlobeNewswire
GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO
GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO PHILADELPHIA and OXFORD, United Kingdom, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Adaptimmune ...
27.03.17 - GlobeNewswire
Adaptimmune Therapeutics plc Announces Closing of Public Offering and Exercise of Underwriters' Option to Purchase Additional American Depositary Shares
Adaptimmune Therapeutics plc Announces Closing of Public Offering and Exercise of Underwriters' Option to Purchase Additional American Depositary Shares PHILADELPHIA and ...
22.03.17 - GlobeNewswire
Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares
Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares PHILADELPHIA and OXFORD, United Kingdom, March 22, 2017 (GLOBE NEWSWIRE) -- ...

Newssuche

Videos

newspaper
17.05.24 +7,67%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »